New drug trial offers hope for Tough-to-Treat esophageal cancer
NCT ID NCT07417735
Summary
This study compares a new drug called SYS6010 against standard chemotherapy for people with advanced esophageal cancer that has worsened after previous treatment. About 436 participants will be randomly assigned to receive either the new drug or their doctor's choice of chemotherapy. The main goals are to see if SYS6010 helps patients live longer without their cancer getting worse and if it's safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED/METASTATIC/RECURRENT ESCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.